[The efficacy of intravenous alendronate for osteoporosis in patients with severe motor intellectual disabilities].

Kaga, Yoshimi; Ishii, Sayaka; Kuroda, Itaru; Kamiya, Yuko; Nakamura, Kousuke; Kanemura, Hideaki; Sugita, Kanji; Aihara, Masao

Kaga, Yoshimi; Ishii, Sayaka; Kuroda, Itaru; Kamiya, Yuko; Nakamura, Kousuke; Kanemura, Hideaki; Sugita, Kanji; Aihara, Masao.

No To Hattatsu ; 49(2): 113-9, 2017 03.

Article in Ja | MEDLINE | ID: mdl-30113151

Subject(s)

Alendronate/therapeutic use; Bone Density Conservation Agents/therapeutic use; Intellectual Disability/complications; Movement Disorders/complications; Osteoporosis/drug therapy; Adult; Alendronate/administration & dosage; Bone Density Conservation Agents/administration & dosage; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Osteoporosis/complications; Young Adult

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Osteoporosis / Alendronate / Bone Density Conservation Agents / Intellectual Disability / Movement Disorders Limits: Adult / Female / Humans / Male / Middle aged Language: Ja Journal: No To Hattatsu Year: 2017 Type: Article

Search on Google

XML

PubMed Links